SGMO icon

Sangamo Therapeutics

196 hedge funds and large institutions have $477M invested in Sangamo Therapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 67 increasing their positions, 46 reducing their positions, and 23 closing their positions.

Holders
196
Holders Change
+9
Holders Change %
+4.81%
% of All Funds
3.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
67
Reduced
46
Closed
23
Calls
$2.45M
Puts
$1.97M
Net Calls
+$478K
Net Calls Change
-$539K
Name Market Value Shares Shares
Change
Shares
Change %
SAM
201
Shell Asset Management
Netherlands
-42,138 Closed
DU
202
Delphia (USA)
Ontario, Canada
-31,498 Closed
BCM
203
Bayesian Capital Management
New York
-31,000 Closed
CC
204
Corton Capital
Ontario, Canada
-28,707 Closed
Handelsbanken Fonder
205
Handelsbanken Fonder
Sweden
-28,246 Closed
PHK
206
Point72 Hong Kong
Hong Kong
-28,019 Closed
Balyasny Asset Management
207
Balyasny Asset Management
Illinois
-25,900 Closed
PAG
208
Private Advisor Group
New Jersey
-12,631 Closed
KAS
209
Kestra Advisory Services
Texas
-11,518 Closed
BCM
210
Bourgeon Capital Management
Connecticut
-2,550 Closed
AP
211
Arlington Partners
Alabama
-2,000 Closed
CAPTRUST Financial Advisors
212
CAPTRUST Financial Advisors
North Carolina
-1,238 Closed
RIM
213
Rockbridge Investment Management
New York
-905 Closed
BCV
214
Banque Cantonale Vaudoise
Switzerland
-93 Closed
BHWM
215
Beaird Harris Wealth Management
Texas
$0 87
HWA
216
HHM Wealth Advisors
Tennessee
$0 50
HT
217
HAP Trading
New York
Wolverine Trading
218
Wolverine Trading
Illinois
GWM
219
Geneos Wealth Management
Colorado
$0 200
CFGS
220
Concourse Financial Group Securities
Alabama
CAL
221
Capital Advisors Ltd
Ohio
$0 93
LC
222
Lindbrook Capital
California
$0 76 +76 New